MECARDIS-H 40mg Tablet 2x14s

 310.00

Manufactured by:
Active Pharmaceutical Ingredient:
Drug Strength: 40mg
Drug Form : Tablet
Pack Size : 2x14s
Rs. 11 per Tablet
28 Tablet per pack
14 Tablet in each strip
Rs.155 per strip

Telmisartan:40mg + Hydrochlorothiazide:12.5mg | Angiotensin II receptor anatgonists

Alternate brands of MECARDIS-H 40mg Tablet 2x14s

Brand Name Price Savings
TELSARTA-D 40mg Tablet 14s  294.00 You can save 16
TELSARTA-D 40mg Tablet 28s  589.00 You will pay -279 more
TELMIS-H 40mg Tablet 14s  275.00 You can save 35
MISARTAN -H 40mg Tablet 10s  310.00 You can save 0
MISARTAN -H 40mg Tablet 28s  589.00 You will pay -279 more
List of alternate brands

Manufactured / Marketed By : Maple Product Form : TabletPack Size : 2x14sIngredients : Telmisartan:40mg + Hydrochlorothiazide:12.5mgGeneric Category : Angiotensin II receptor anatgonists

Reviews

There are no reviews yet.

Be the first to review “MECARDIS-H 40mg Tablet 2x14s”

How it works

MECARDIS-H 40mg Tablet 2x14s works by relaxing blood vessels so blood can flow more easily

Side effects

Major & minor side effects for MECARDIS-H 40mg Tablet 2x14s

  • Increased urination severe
  • Itching or rash severe
  • Abdominal and stomach pain severe
  • Dry mouth severe
  • Dry mouthJoint pain, stiffness, and swelling
  • Cramping
  • Chest pain severe
  • Changes in vision severe
  • Dizziness severe
  • Increased heartbeat severe
  • Difficulty or painful urination severe
  • Headache
  • Diarrhea
  • Back pain
  • Weakness
  • Muscle pain
  • Fever

Uses of MECARDIS-H 40mg Tablet 2x14s

What is it prescribed for?

  • Hypertension

    This medicine is used in the treatment of high blood pressure which may be caused by genetic or environmental factors.

Concerns

Frequently asked questions

  • Onset of action

    The effect of this medicine can be observed within 2 hours of administration of the dose.

  • Duration of Effect

    The effect of this medicine lasts for an average duration of 24 hours.

  • Safe with Alchohol?

    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, lightheadedness, and fainting. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.

  • Is it habit forming?

    No habit forming tendency has been reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women except in life-threatening conditions. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to hydrochlorothiazide, other sulfonamides, telmisartan, or any other angiotensin receptor blockers.

  • Anuria

    This medicine is not recommended for use in patients with anuria, a condition where the kidney is unable to produce urine.

  • Cholestasis and biliary obstructive disorders

    This medicine is not recommended for use in patients with cholestasis and biliary obstructive disorders due to the increased risk of severe adverse effects.

  • Aliskiren

    Coadministration of aliskiren and this combination medicine is not recommended due to the increased risk of serious adverse effects. This risk is especially higher in the elderly population and in patients with diabetes and kidney diseases.

  • Severe renal impairment

    This medicine is not recommended for use in patients with severe renal impairment (CrCl < 30 ml/min) due to the increased risk of serious adverse effects.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women except in life-threatening conditions. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

General Warnings
  • Systemic Lupus Erythematosus

    This medicine should be used with caution in patients with a known history of Systemic Lupus Erythematosus due to the increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

  • Volume and electrolyte depletion

    This medicine may alter the blood volume and electrolyte levels in some patients. This may cause dizziness, dry mouth, and acid-base imbalance. This risk is especially higher in patients suffering from kidney and liver diseases. Close monitoring of blood pressure and electrolyte levels is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

  • Renal diseases

    This medicine may cause Azotemia in patients with a known history of severe renal diseases. Close monitoring of kidney function is necessary while taking this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

  • Use in athletes

    This medicine is not recommended to be used by athletes as per the World Anti-Doping Agency (WADA).

  • Hyperkalemia

    This medicine may increase the potassium levels in the blood (hyperkalemia). This may cause serious side effects such as fatal cardiac rhythm irregularities. It is advised to avoid potassium-rich foods (potatoes, bananas) and other medicines that may increase potassium levels (ACE inhibitors and potassium supplements) during treatment with this medicine.

  • Impaired liver function

    This medicine should be used with extreme caution in patient's suffering from liver diseases due to an increase in the risk of serious adverse effects including coma. Close monitoring of liver function is advised while taking this medicine. Report any symptoms of confusion or jaundice to the doctor on priority. Replacement with a suitable alternative may be required based on the clinical condition.

  • Pediatric population

    This medicine is not recommended for use in children since the safety and efficacy of use are not clinically established.

  • Hypersensitivity reactions

    Hypersensitivity reactions to this medicine may occur in patients with or without a history of allergy or bronchial asthma but are more likely in patients with such a history.

Dosage

  • Missed Dose

    Take the missed dose as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose. Do not double your dose to make up for the missed one.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Interaction with Medicines
  • Dexamethasone moderate
  • Aliskiren severe
  • Captopril severe
  • Insulin moderate
  • Antidepressants moderate
  • Nonsteroidal anti-inflammatory medicines moderate
Disease interactions
  • moderate

    This medicine should be used with caution in patients with a known history of diabetes mellitus due to the increased risk of altered blood glucose levels. Close monitoring of blood glucose levels is advised for such patients. Replacement with a suitable alternative may be required based on the clinical condition.

  • moderate

    This medicine should be used with caution in patients with a history of gout or chronic renal failure due to the increased risk of hyperuricemia. Close monitoring of uric acid level is recommended for such patients. Replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

  • moderate

    This medicine should be used with extreme caution in patients with congestive heart failure due to the increased risk of renal impairment and worsening of the patient's condition. Close monitoring of heart function, blood pressure, and kidney function is recommended for such patients. Replacement with a suitable alternative may be required based on the clinical condition.

  • severe

    This medicine should be used with caution in patients who are sodium depleted and/or volume depleted since it may increase the risk of hypotension. The volume depleted and/or sodium depleted state should be corrected before starting the therapy. Vital signs should be monitored closely during therapy with this medicine.

  • moderate

    This medicine is not recommended for use in patients with a history of angioedema or a family history of angioedema due to the increased risk of recurrent symptoms. Report any incidence of swelling of the face, lips, and eyes to the doctor on priority. Replacement with a suitable alternative may be required based on the clinical condition.

  • moderate

    This medicine should be used with caution in patients with hyperparathyroidism since it may worsen the patient's condition. This risk is especially higher with prolonged use of the medication. Close monitoring of calcium levels is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Food interactions
  • It is advised to avoid potassium containing foods and supplements while taking this medicine due to the increased risk of weakness, confusion, irregular heartbeat, etc. Report any unusual symptoms to the doctor immediately. Your dietitian/doctor may suggest appropriate changes in your diet based on your clinical condition.

General Instructions

Take this medicine exactly as advised by your doctor. Do not take in larger amounts than prescribed. It is advised to take this medicine at daytime to prevent sleep disturbance. Drink an adequate amount of water. Monitoring of kidney function and electrolytes levels is necessary while taking this medicine. Report any adverse effects to the doctor on priority. Do not stop the use of this medicine without consulting your doctor.

Other details

  • Can be taken with or without food, as advised by your doctor
  • To be taken as instructed by doctor
  • May cause sleepiness

References

Additional Information>

One of the following licensed pharmacy from the nearest location will deliver MECARDIS-H 40mg Tablet 2x14s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Medicalstore.com.pk © All rights reserved

Made with ❤ by Dairah

Shopping Cart